October PBS listings swell to 16

Posted 2 October 2024 AM 

There are 16 new additions to the PBS this month covering first-timers, expansions of existing drugs, three biosimilars, and a generic, Pharma in Focus analysis shows.

CSL Seqirus has landed two new treatments on the scheme, including fish oil-based heart drug Vazkepa, which it secured local commercialisation rights to from Irish company Amarin in March 2023.

To see the whole article, please login